AP /
November 11, 2012
BOSTON (AP) — The state’s oversight of compounding pharmacies will be the
subject of a legislative hearing.
Massachusetts lawmakers called for the Statehouse hearing on Wednesday in the
wake of a nationwide fungal meningitis outbreak linked to a steroid distributed
by Framingham-based New England Compounding Center. The outbreak has sickened
more than 400 people and caused more than 30 deaths.
The state pharmacy board is under scrutiny for its handling of past
complaints against the company. The board’s director, James Coffey, was fired
last week.
The Massachusetts board falls under the umbrella of the state Department of
Public Health. The agency also faces questions about its oversight of a
now-closed state lab, where a former chemist has been accused of mishandling
drug tests.
Source found here
Source found here
No comments:
Post a Comment